Regenxbio (RGNX) Share-based Compensation Growth (5y) (2019 - 2025)
Regenxbio (RGNX) Share-based Compensation Growth (5y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Regenxbio | 528.62 Mn | 298.55 Mn | 21.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.01% |
| Sep 30, 2025 | 2.29% |
| Jun 30, 2025 | 51.15% |
| Mar 31, 2025 | 1.26% |
| Dec 31, 2024 | 6.78% |
| Sep 30, 2024 | 6.65% |
| Jun 30, 2024 | 5.85% |
| Mar 31, 2024 | 10.92% |
| Dec 31, 2023 | 11.28% |
| Sep 30, 2023 | 17.91% |
| Jun 30, 2023 | 21.41% |
| Mar 31, 2023 | 27.77% |
| Dec 31, 2022 | 27.47% |
| Sep 30, 2022 | 30.24% |
| Jun 30, 2022 | 33.00% |
| Mar 31, 2022 | 33.04% |
| Dec 31, 2021 | 35.58% |
| Sep 30, 2021 | 39.71% |
| Jun 30, 2021 | 43.26% |
| Mar 31, 2021 | 45.03% |